Medical Device | October 11, 2021
Kaneka Covid-19 kits detect all four variants simultaneously
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Now all districts of the country will have commissioned PSA Oxygen plants
A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)
Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries
Subscribe To Our Newsletter & Stay Updated
